UZWIL, SWITZERLAND — During an extraordinary general shareholders’ meeting on Oct. 8, the board of directors for Bühler Group unanimously approved the appointment of Christoph Goppelsroeder to the board.

Goppelsroeder began his career at The Boston Consulting Group. From 1994 to 2003, he held management positions at Roche Vitamins in Switzerland, Belgium, and the US. He joined DSM through its acquisition of Roche’s Vitamins business in 2003 when he co-led the integration of Roche Vitamins and acted as DSM managing board member from 2005 to 2006. From 2007 to 2012, he was in charge of Syngenta’s Global Seed Care Division.

In 2013, Goppelsroeder was appointed president and CEO of DSM Nutritional Products, DSM’s largest business, and member of DSM’s executive committee. He led the division on a robust growth path, both organically as well as through acquisitions. He retired on April 1.

Goppelsroeder studied civil engineering at ETH in Zurich and earned a master’s in business administration from Insead, Fontainebleau. With his appointment, the board of directors is gaining an experienced executive who has played a crucial role in innovation and who puts customer needs first, Bühler said.

Read more about personnel changes throughout the industry.